Penserra Capital Management LLC Spring Works Therapeutics, Inc. Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$53.3 - $75.84 $60,229 - $85,699	-1,130 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$62.66 - $88.26 $939 - $1,323	15 Added 1.35%	1,130 $71,000
Q2 2021 Aug 12, 2021	BUY	$67.45 - $85.63 $337 - $428	5 Added 0.45%	1,115 $91,000
Q1 2021 May 13, 2021	SELL	$65.1 - $93.59 $976 - $1,403	-15 Reduced 1.33%	1,110 $81,000
Q4 2020 Feb 12, 2021	BUY	$48.36 - $77.92 $54,405 - $87,660	1,125 New	1,125 $81,000

238

69.8M

144K

257K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.6B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.